10-101003771-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001318100.2(LZTS2):āc.673C>Gā(p.Leu225Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000924 in 1,613,142 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.00031 ( 1 hom., cov: 33)
Exomes š: 0.000070 ( 0 hom. )
Consequence
LZTS2
NM_001318100.2 missense
NM_001318100.2 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 0.337
Genes affected
LZTS2 (HGNC:29381): (leucine zipper tumor suppressor 2) The protein encoded by this gene belongs to the leucine zipper tumor suppressor family of proteins, which function in transcription regulation and cell cycle control. This family member can repress beta-catenin-mediated transcriptional activation and is a negative regulator of the Wnt signaling pathway. It negatively regulates microtubule severing at centrosomes, and is necessary for central spindle formation and cytokinesis completion. It is implicated in cancer, where it may inhibit cell proliferation and decrease susceptibility to tumor development. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.034448564).
BS2
High AC in GnomAd4 at 47 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LZTS2 | NM_001318100.2 | c.673C>G | p.Leu225Val | missense_variant | 3/5 | ENST00000454422.2 | NP_001305029.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LZTS2 | ENST00000454422.2 | c.673C>G | p.Leu225Val | missense_variant | 3/5 | 2 | NM_001318100.2 | ENSP00000416972.2 | ||
LZTS2 | ENST00000370220.1 | c.673C>G | p.Leu225Val | missense_variant | 2/4 | 1 | ENSP00000359240.1 | |||
LZTS2 | ENST00000370223.7 | c.673C>G | p.Leu225Val | missense_variant | 3/5 | 1 | ENSP00000359243.3 | |||
LZTS2 | ENST00000426584.5 | c.673C>G | p.Leu225Val | missense_variant | 3/3 | 3 | ENSP00000407713.1 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152236Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
47
AN:
152236
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000214 AC: 53AN: 248038Hom.: 0 AF XY: 0.000156 AC XY: 21AN XY: 134598
GnomAD3 exomes
AF:
AC:
53
AN:
248038
Hom.:
AF XY:
AC XY:
21
AN XY:
134598
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000698 AC: 102AN: 1460788Hom.: 0 Cov.: 31 AF XY: 0.0000688 AC XY: 50AN XY: 726702
GnomAD4 exome
AF:
AC:
102
AN:
1460788
Hom.:
Cov.:
31
AF XY:
AC XY:
50
AN XY:
726702
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000308 AC: 47AN: 152354Hom.: 1 Cov.: 33 AF XY: 0.000416 AC XY: 31AN XY: 74502
GnomAD4 genome
AF:
AC:
47
AN:
152354
Hom.:
Cov.:
33
AF XY:
AC XY:
31
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
15
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2024 | The c.673C>G (p.L225V) alteration is located in exon 3 (coding exon 2) of the LZTS2 gene. This alteration results from a C to G substitution at nucleotide position 673, causing the leucine (L) at amino acid position 225 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Pathogenic
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
1.0
.;D;D
Vest4
0.55, 0.55
MVP
MPC
0.87
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at